News & Announcements - Agency Announcements, Updates & Revisions

  • New  Change in the NIH Continuous Submission Policy 12-4-13
  • NIH Loan Repayment Program-researchers can receive up to $35,000 annually to help repay student loans: http://www.lrp.nih.gov 9-11-12
  • Fellows and Residents Research Forum 6-1-12

    The Fellows and Residents Research Forum was initiated over 25 years ago to provide the Fellows and the Residents in the Department of Medicine with an opportunity to present their research effort to the Members of the Department. The Forum is a reflection of the ongoing research activities in the Department, and a year-end summation of the projects carried out by the Fellows and Residents.
    Wednesday, June 6, 2012 at the Medical Education and Research Building.

  • Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP) Opportunities 4-19-12

    The Fiscal Year 2012 (FY12) Defense Appropriations Act provides research funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP). Each Program Announcement is available electronically for downloading from the Grants.gov website (http://www.grants.gov), and will be available within 48 hours on the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml) and the CDMRP eReceipt System (https://cdmrp.org).

  • Notice of Requirement for Electronic Submission of Just-in-Time Information and Related Business Process Changes Beginning April 20, 2012 3-30-12

    Certain NIH programs and award mechanisms use Just-in-Time (JIT) procedures to enable specific elements of a grant application to be submitted later in the application process, following review when the application is still under consideration for funding. This procedure reduces the time to award while ensuring the accuracy and timeliness of information needed to award NIH grants. To reduce application confusion and to minimize requests from NIH staff for JIT submissions, NIH is revising its business processes so applicants will have better information on when JIT submissions are required, and to require electronic submission of JIT information through the eRA Commons as of April 20, 2012.

  • Department of Defense Prostate Cancer Research Program Funding Opportunities for Fiscal Year 2012 3-23-12

    The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $80 million (M) to the Department of Defense Prostate Cancer Research Program (PCRP) to support innovative, high-impact prostate cancer research. The mission of the PCRP is to eliminate death and suffering from prostate cancer. This program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

    Please inform researchers at the Temple University interested in the Prostate Cancer Research Program that eleven award mechanisms have been released. FY12 PCRP program announcements and general application instructions are available on Grants.gov. Preapplication due dates vary from April 24 - July 26, please confirm the appropriate date for the mechanism you are interested in.

  • Department of Defense Lung Cancer Research Program Funding Opportunities for Fiscal Year 2012 3-20-12

    The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10.2 Million (M) to the Department of Defense Lung Cancer Research Program's (LCRP) to support innovative, high-impact lung cancer research. The LCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

    The LCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY12 LCRP Program Announcements and General Application Instructions for the following mechanisms are anticipated to be posted on Grants.gov in April 2012. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

  • Department of Defense Gulf War Illness Research Program Funding Opportunities for Fiscal Year 2012 3-13-12

    The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10 million (M) to the Department of Defense Gulf War Illness Research Program (GWIRP) to support innovative, high-impact research into Gulf War Illness. The Department of Defense Gulf War Illness Research Program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

    Please inform researchers interested in Gulf War Illness Research Programs that three award mechanisms have been released. FY12 GWIRP program announcements and general application instructions are available on Grants.gov.

  • Department of Defense Ovarian Cancer Research Program Funding Opportunities for Fiscal Year 2012 3-1-12
  • Frequently Asked Questions on Change to NIH Salary Cap in FY2012 2-24-12
  • New NIH Policy on Efficient Spending Related to Grants Supporting Conferences and Meetings 1-30-12
  • Department of Defense Gulf War Illness Research Program Anticipated Funding Opportunities for Fiscal Year 2012 1-30-11

    The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10 million (M) to the Department of Defense Gulf War Illness Research Program (GWIRP) to support innovative, high-impact research into Gulf War Illness. The Department of Defense Gulf War Illness Research Program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP). Requests for email notification of the release of CDMRP program announcements may be sent to help@cdmrp.org. For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil)

  • Department of Defense Breast Cancer Research Program Funding Opportunities for Fiscal Year 2012  1-23-12

    The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $120 million (M) to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research. The BCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

    The BCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY12 BCRP program announcements and general application instructions for the following award mechanisms are anticipated to be posted on Grants.gov in February 2012. This pre-announcement should not be construed as an obligation by the government. Submission deadlines are not available until the program announcements are released.

    Clinical Translational Research Award:
    Eligibility: Investigators at or above the level of Assistant Professor (or equivalent).
    Key Mechanism Elements:
    *Supports the acceleration of research with a high potential for direct clinical translation that will result in significant improvements over current approaches to breast cancer prevention and/or therapy.
    *Applications will be supported in two stages. Stage I will enable completion of preclinical translational studies and Food and Drug Administration approvals (if needed). Stage II will initiate and execute the prospective clinical trial *Preliminary data are required.
    *Preproposal is required; application submission is by invitation only.
    Maximum funding of $12M for direct costs (plus indirect costs).
    Period of performance not to exceed 5 years.

    Era of Hope Scholar Award:
    Eligibility: Independent, non-mentored investigators within 6 years of their last mentored position as of the application submission deadline.
    Key Mechanism Elements:
    *Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields.
    *Individuals should exhibit strong potential for leadership in the breast cancer community.
    Maximum funding of $2.5M for direct costs (plus indirect costs).
    Period of performance not to exceed 5 years.

    Idea Award:
    Eligibility: Investigators at all academic levels (or equivalent).
    Key Mechanism Elements:
    *Supports innovative, high-risk/high-reward research ideas that have extraordinary potential to yield highly impactful data.
    *Innovation and Impact are the most important review criteria.
    *Preliminary data are allowed, but not required.
    *Partnering Principal Investigator (PI) Option supports combining expertise of two PIs to more effectively address a research question.
    *Preproposal is required; limit of one preproposal per PI; application submission is by invitation only.
    *Maximum funding of $375K for direct costs (plus indirect costs).
    Period of performance not to exceed 2 years.

    Impact Award:
    Eligibility: Investigators at or above the level of Assistant Professor (or equivalent).
    Key Mechanism Elements:
    *Supports unique research projects that focus on scientific and clinical breast cancer issues, which, if successfully addressed, could ultimately have a major impact on the understanding, prevention, and/or treatment of breast cancer.
    *Preproposal is required; application submission is by invitation only.
    Maximum funding of $2M for direct costs (plus indirect costs).
    Period of performance not to exceed 5 years.

    Innovator Award:
    Eligibility: Associate Professor or above (or equivalent).
    Key Mechanism Elements:
    *Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field.
    *Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the end of breast cancer.
    *Nomination is required and self-nominations are accepted; application submission is by invitation only.
    Maximum funding of $5M for direct costs (plus indirect costs).
    Period of performance not to exceed 5 years.

    Postdoctoral Fellowship Award:
    Eligibility: Principal Investigator: Doctoral graduates (Ph.D. or M.D.). Clinical investigators are eligible to apply. Must have no more than 2 years experience in the proposed research setting and no more than 4 years of postdoctoral research experience as of the application deadline.
    Mentor or formal co-mentor must have breast cancer research experience, including current funding and publications.
    Key Mechanism Elements:
    *Supports the training of exceptionally talented recent doctoral graduates.
    *Individualized training program and mentorship should prepare the PI for an independent career at the forefront of breast cancer research.
    *Proposed research should address a critical problem in breast cancer research.
    Maximum funding of $300K for direct costs ($100K per year; plus indirect costs).
    Period of performance not to exceed 3 years.

    Transformative Vision Award:
    Eligibility: Independent investigators at any academic level (or equivalent).
    Key Mechanism Elements:
    *Supports a research effort to realize a vision for dramatically affecting the prevention or treatment of breast cancer as quickly as possible.
    *Teams must include consumer advocates who will be integrated into the planning and implementation of the research project.
    *Applications with multiple PIs are allowed; however, PIs should have demonstrated experience in successfully leading large, focused projects.
    *Preproposal is required; application submission is by invitation only.
    Period of performance not to exceed 5 years.
    Maximum funding of $12M for direct costs (plus indirect costs).

    All applications must conform to the final program announcements and application instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

    A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the program announcements are released. Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

    If you would like to request a different recipient to these messages please reply back with the corrected information.

    Point of Contact:
    CDMRP Public Affairs
    301-619-9783
    CDMRP.PublicAffairs@amedd.army.mil

  • Notice of Salary Limitation on Grants, Cooperative Agreements, and Contracts 1-20-12

    As part of the federal budget for the 2012 fiscal year, which was approved by Congress and signed into law last month, the NIH's salary cap for outside researchers was set at $179,700, down $20,000 from last year's level.

  • Request for proposals Basil O'connor Starter Scholar Research award 2013 program 1-10-12
  • Request for proposals for the Prematurity Research Initiative (PRI) 2013 program 1-10-12
  • Request for proposals year 2013 March of Dimes Research program 1-10-12
  • New NEA Guidelines  1-10-12

    Application guidelines for the next round of Grants for Arts Projects are now available on the NEA's website. To view the guidelines, go to www.arts.gov/grants/apply, select the field or discipline most relevant to your project, and choose Grants for Arts Projects from the list of funding opportunities.

    Organizations may apply under the following categories:
    • Art Works: To support the creation of art that meets the highest standards of excellence, public engagement with diverse and excellent art, lifelong learning in the arts, and the strengthening of communities through the arts. Within these areas, innovative projects are strongly encouraged. Grants generally range from $10,000 to $100,000. (Two application deadlines: March 8 and August 9, 2012)
    • Challenge America Fast-Track: To support projects that extend the reach of the arts to underserved populations. Grants are for $10,000. (Application deadline: May 24, 2012)

    For questions about the guidelines or your application, see "Agency Contacts" for the NEA staff that is most appropriate for your project.

  • The Pacific Southwest Regional Center of Excellence (PSWRCE), an NIAID National Center based at UC Irvine, has just announced its call for Developmental Research Projects in Biodefense & Emerging Infectious Diseases. 12-7-11

    Projects are for a maximum of $150,000 direct costs per year. Applications are due January 9, 2012. Applicants are required to use the modified PHS398 forms posted here. Materials should be submitted to: pswrce@uci.edu. Note that, while the Center generally serves the Southwest region (Arizona, California, Hawaii and Nevada) there is no regional restriction for the present call.

    PSWRCE Request For Proposals
  • Department of Commerce (DOC): FY 2012 - 2013 Broad Agency Announcement (BAA) Grant  12-2-11
  • Department of Defense (DOD): Defense Threat Reduction Agency  12-2-11
  • National Science Foundation(NSF): Major Research Instrumentation Program  12-2-11
  • NIH Shared Instrumentation - Call for Proposals, Due March 21, 2012
  • The Energy Commercialization Institute Announces Opportunity

    The Energy Commercialization Institute (ECI) is the region's first partnership accelerating alternative and clean energy technology development and commercialization, through translational research and sponsored research funding. ECI is focusing on high-impact energy generation, transportation and conservation. The Institute pools intellectual property from participating institutions, providing dedicated technology transfer services with expertise to promote energy commercialization. It offers corporations a single point of negotiation for IP licensing, independent of the number of institutions with ownership of that IP. Multi-institution or single institution teams with an executed corporate SRA are eligible to apply. Please see attached application for additional eligibility and funding guidelines. All applications will be reviewed by the ECI Operations Committee (OPS) for eligibility, adherence to stated requirements, and overall appropriateness of the team and topic. Proposals meeting these criteria will be reviewed by the ECI OPS, Energy Advisory Committee (EAC), external reviewers drawn from regional universities, industry, venture capital, and economic development organizations with demonstrated expertise in technology development and commercialization. Recommendations by the ECI OPS and EAC are made to the ECI's Oversight Committee (OC) for final approval. Application package is here. If there are any questions you may call Khalilah Parham Mangum, Program Administrator, Ben Franklin Technology Partners/SEP at (215) 972-6700 ext. 3226 or Anthony Green, VP, Technology Commercialization, Ben Franklin Technology Partners/ SEP at (215)972-6700 ext. 3713.

  • The National Institutes of Health (NIH) announces the publication of the revised NIH Grants Policy Statement (NIHGPS, rev. 10/1/2011)
  • American Heart Association Membership/Application Fee

    Beginning with the winter 2012 deadlines, applicants are required to either be an AHA Professional Member or to pay $100 per application submission. Professional membership levels start at $75. This helps defer the administrative cost of processing applications.

  • Elimination of NIH Error Window
    Beginning with due dates on or after January 25, 2011, NIH, AHRQ and NIOSH eliminated the error correction window from the application submission process. Eliminating the error correction window is intended to ensure consistent and fair deadlines for all applicants and better align these agencies’ application submission processes with the submission processes of other federal agencies. More information is available at: http://grants.nih.gov/grants/guide/notice-files/not-od-10-123.html

  • NSF Data Management Plan Requirement

    Proposals to NSF submitted or due on or after January 18, 2011, must include a supplementary document of no more than two pages labeled “Data Management Plan”. This supplementary document should describe how the proposal will conform to NSF policy on the dissemination and sharing of research results. See the NSF Grant Proposal Guide (GPG) Chapter II.C.2.j for full policy implementation. Information on requirements by Directorate, Office, Division, Program, or other NSF Units is available here: http://www.nsf.gov/bfa/dias/policy/dmp.jsp

  • NIH, AHRQ, CDC, FDA and NIOSH to Release Updated Electronic Application Forms – ADOBE-FORMS-B2
    The new ADOBE-FORMS-B2 packages are being used with new funding opportunity announcements (FOAs) posted on/after July 22, 2011. In addition, NIH will reissue R01, R03, and R21 parent announcements with the new forms on July 22 and expire the current parent R01, R03, and R21 FOAs on January 8, 2012. More information. . .

Connections